International Congress on Neuropathic Pain 2025
We had the opportunity to present at NeuPSIG 2025 in Berlin, sharing our latest findings in neuropathic pain research. The conference offered...
in vivo pain models
Approaches to Designing Preclinical Studies That Reflect Clinical Reality
Bridging the gap between preclinical and clinical research remains one of the most pressing challenges in drug development. While early-stage studies...
EWMA 2025: Groundbreaking AI-Driven Advancements in Wound Healing Models
MD Biosciences presented at the European Wound Management Association 2025 in Barcelona. Dr. Avital Schauder showcased groundbreaking research on...
Animal Welfare in Preclinical Studies
Maintaining high standards of animal welfare in preclinical research is crucial for both ethical integrity and scientific reliability. Proper pig...
Acute Kidney Injury: Insights From In Vivo Biomarker Assessments
In vivo Acute Kidney Injury (AKI) models are commonly used to study renal damage and evaluate potential therapeutic interventions. Several models...
Behavioral Assessments in Preclinical Pain Models
Chronic pain affects 1 in 5 adults in the US, making it one of the most common chronic conditions 1. Approved analgesics often lack efficacy and have...
New Developments: Innovative Cold Pain Testing Methods
Cold testing in rats serves as a crucial tool in pain research, particularly in studying neuropathic pain and assessing the effectiveness of drugs....
Models of Acute Inflammatory Pain
Acute inflammatory pain is commonly associated with tissue injury and is characterized by neuronal plasticity involving both central and peripheral...
Advancing Parkinson’s Research: Insights from Diverse Disease Models
Parkinson’s Disease (PD) is a progressive neurodegenerative movement disorder that affects millions of people worldwide. PD is characterized by the...